Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

jamjoom pharmaceuticals company, saudi arabia - alpha tocoferil - capsule - 400 mg

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 40 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 60 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 80 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 20 mg - ziprasidone - ziprasidone - •schizophrenia.treatment of schizophrenia and for maintenance of clinical improvement during continuationtherapy in adults.•bipolar mania.ziprasidone is indicated as monotherapy in the treatment of adults with manic or mixed episodes associatedwith bipolar disorder with or without psychotic features.•bipolar disorder.maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - apo-venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - apo-venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - blooms the chemist venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - blooms the chemist venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.